J&J's 6% slide on an imperfect quarter is a gift to prospective buyers
J&J's pharmaceutical division is humming along, and the MedTech problems should be temporary.
J&J's 6% slide on an imperfect quarter is a gift to prospective buyers
Trade News on 2026-10-13 markets note: J&J's 6% slide on an imperfect quarter is a gift to prospective buyers J&J's pharmaceutical division is humming along, and the MedTech problems should… Primary source: original at CNBC Finance (cnbc.com).
Read also
We're raising our Micron price target after an incredible quarter and robust guidance
We're upgrading our Goldman Sachs rating after a strong quarter bodes well for the future
7 Stocks With Technical Bottoms in Sight — What Investors Should Watch Now
